262 related articles for article (PubMed ID: 12373596)
1. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
Becker JC; Terheyden P; Kämpgen E; Wagner S; Neumann C; Schadendorf D; Steinmann A; Wittenberg G; Lieb W; Bröcker EB
Br J Cancer; 2002 Oct; 87(8):840-5. PubMed ID: 12373596
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients.
Voelter V; Schalenbourg A; Pampallona S; Peters S; Halkic N; Denys A; Goitein G; Zografos L; Leyvraz S
Melanoma Res; 2008 Jun; 18(3):220-4. PubMed ID: 18477897
[TBL] [Abstract][Full Text] [Related]
3. [Hepatic intra-arterial bio-chemotherapy for the treatment of melanoma patients with liver metastasis: a phase II clinical study].
Cui CL; Chi ZH; Yuan XQ; Lian HY; Si L; Guo J
Ai Zheng; 2008 Aug; 27(8):845-50. PubMed ID: 18710619
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma.
Siegel R; Hauschild A; Kettelhack C; Kähler KC; Bembenek A; Schlag PM
Eur J Surg Oncol; 2007 Jun; 33(5):627-32. PubMed ID: 17196362
[TBL] [Abstract][Full Text] [Related]
5. Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients.
Ridolfi L; Fiorentini G; Guida M; Michiara M; Freschi A; Aitini E; Ballardini M; Bichisao E; Ridolfi R;
Melanoma Res; 2009 Apr; 19(2):100-5. PubMed ID: 19262411
[TBL] [Abstract][Full Text] [Related]
6. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
Célérier P; Dreno B; Bureau B; Litoux P
Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787
[TBL] [Abstract][Full Text] [Related]
7. [Malignant melanoma of the uvea].
Boaziz C; Mazeron JJ; Morere JF; Breau JL; Israël L
Bull Cancer; 1993 Jul; 80(7):577-83. PubMed ID: 8204938
[TBL] [Abstract][Full Text] [Related]
8. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine.
Melichar B; Voboril Z; Lojík M; Krajina A
Hepatogastroenterology; 2009; 56(93):1157-62. PubMed ID: 19760961
[TBL] [Abstract][Full Text] [Related]
9. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
Pyrhönen S; Hahka-Kemppinen M; Muhonen T; Nikkanen V; Eskelin S; Summanen P; Tarkkanen A; Kivelä T
Cancer; 2002 Dec; 95(11):2366-72. PubMed ID: 12436444
[TBL] [Abstract][Full Text] [Related]
10. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC
Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785
[TBL] [Abstract][Full Text] [Related]
11. Uveal melanoma: natural history and treatment options for metastatic disease.
Wöll E; Bedikian A; Legha SS
Melanoma Res; 1999 Dec; 9(6):575-81. PubMed ID: 10661768
[TBL] [Abstract][Full Text] [Related]
12. Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
Niederkorn A; Wackernagel W; Artl M; Schwantzer G; Aigner B; Richtig E
Acta Ophthalmol; 2014 Dec; 92(8):e696-7. PubMed ID: 24774993
[No Abstract] [Full Text] [Related]
13. Intraarterial chemotherapy of malignant melanoma metastatic to the liver.
Melichar B; Dvorák J; Jandík P; Tousková M; Solichová D; Megancová J; Voboril Z
Hepatogastroenterology; 2001; 48(42):1711-5. PubMed ID: 11813606
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
Schuster R; Lindner M; Wacker F; Krössin M; Bechrakis N; Foerster MH; Thiel E; Keilholz U; Schmittel A
Melanoma Res; 2010 Jun; 20(3):191-6. PubMed ID: 20335820
[TBL] [Abstract][Full Text] [Related]
15. Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment.
Heusner TA; Antoch G; Wittkowski-Sterczewski A; Ladd SC; Forsting M; Verhagen R; Scheulen M
Rofo; 2011 Dec; 183(12):1151-60. PubMed ID: 22033849
[TBL] [Abstract][Full Text] [Related]
16. Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.
Leyvraz S; Piperno-Neumann S; Suciu S; Baurain JF; Zdzienicki M; Testori A; Marshall E; Scheulen M; Jouary T; Negrier S; Vermorken JB; Kaempgen E; Durando X; Schadendorf D; Gurunath RK; Keilholz U
Ann Oncol; 2014 Mar; 25(3):742-746. PubMed ID: 24510314
[TBL] [Abstract][Full Text] [Related]
17. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy.
Leyvraz S; Spataro V; Bauer J; Pampallona S; Salmon R; Dorval T; Meuli R; Gillet M; Lejeune F; Zografos L
J Clin Oncol; 1997 Jul; 15(7):2589-95. PubMed ID: 9215829
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients.
Egerer G; Lehnert T; Max R; Naeher H; Keilholz U; Ho AD
Int J Clin Oncol; 2001 Feb; 6(1):25-8. PubMed ID: 11706523
[TBL] [Abstract][Full Text] [Related]
19. Artesunate in the treatment of metastatic uveal melanoma--first experiences.
Berger TG; Dieckmann D; Efferth T; Schultz ES; Funk JO; Baur A; Schuler G
Oncol Rep; 2005 Dec; 14(6):1599-603. PubMed ID: 16273263
[TBL] [Abstract][Full Text] [Related]
20. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]